Efficacy of lenvatinib plus pembrolizumab for recurrent endometrial cancer: a focus on the nonendometrioid histology including carcinosarcoma

Post time 2026-10-18 06:48:19

journal：Japanese Journal of Clinical Oncology

Authors：Yoshifumi Takahashi; Yuji Takei; Miku Takadera; Takahiro Koyanagi; Akiyo Taneichi; Yasushi Saga; Hiroyuki Fujiwara

Published date：2026-6-5

DOI：10.1093/jjco/hyag036

PDF link：https://academic.oup.com/jjco/ar ... 7188494/hyag036.pdf

Article link：https://doi.org/10.1093/jjco/hyag036

Article Source：Oxford University Press (OUP)。

Remark：

Post time 2026-10-18 06:48:20

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Oxford] Efficacy of lenvatinib plus pembrolizumab for recurrent endometrial cancer: a focus on the nonendometrioid histology including carcinosarcoma

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Oxford] Efficacy of lenvatinib plus pembrolizumab for recurrent endometrial cancer: a focus on the nonendometrioid histology including carcinosarcoma Copy